Skip to content

CG FUTURE® 638BL32 (UDI 00613994751782)Recalls & reported problems

Medtronic, Inc. · BAND 638BL32 CG FUTURE 10L INSERT · Class 2

All models of CG FUTURE (46)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994751782), received between Oct 21, 2024 and Oct 21, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Calcified” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Calcified1
  • Insufficient Device Problem Information1
  • Intravalvular regurgitation1
  • Patient Device Interaction Problem1

Patient problems

  • Calcium Deposits/Calcification1
  • Insufficient Information1
  • Mitral Valve Insufficiency/ Regurgitation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 21, 2024Calcified; Insufficient Device Problem Information; Patient Device Interaction Problem; Intravalvular regurgitation; Calcified; Insufficient Device Problem Information; Patient Device Interaction Problem; Intravalvular regurgitation

    MEDTRONIC RECEIVED ADDITIONAL INFORMATION WHICH STATED THAT THE PATIENT HAD PRESENTED WITH A LOW LEFT VENTRICLE EJECTION FRACTION (EF) OF 20% AND ACUTE DECOMPENSATED HEART FAILURE PRIMARILY BASED ON ACUTE ONSET AORTIC VALVE REGURGITATION. IT WAS REPORTED THAT THE REASON FOR REPLACEMENT OF THE MITRAL BAND WAS SEVERE MITRAL VALVE REGURGITATION. IT WAS REPORTED THAT THE MITRAL ANNULOPLASTY BAND WAS INTACT BUT THERE WAS SEVERE MITRAL ANNULAR CALCIFICATION. IT WAS STATED THAT THE PATIENT IS DOING WELL.

    Patient problems: Calcium Deposits/Calcification; Insufficient Information; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 20492319 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page